Clinical trials
Phase 2 Neoplasm Metastasis trials in Ireland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 4 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 5 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Trials Ireland | 2 |
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Astellas Pharma Inc | 1 |
| ETOP IBCSG Partners Foundation | 1 |
| Incyte Corporation | 1 |
| Janssen Research & Development, LLC | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
| NantCell, Inc. | 1 |
| Puma Biotechnology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 13 |
| Breast Neoplasms | 6 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Acrocephalosyndactylia | 1 |
| Adenocarcinoma of Lung | 1 |
| Carcinoma, Transitional Cell | 1 |
| Lung Neoplasms | 1 |
| Pleural Effusion, Malignant | 1 |
| Prostatic Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.